University of Sydney: Sotrovimab Shown to Cause COVID-19 Treatment-Resistant Mutations
March 10, 2022
March 10, 2022
SYDNEY, Australia, March 10 (TNSJou) -- The University of Sydney issued the following news:
Australian researchers have uncovered resistance mutations to Sotrovimab - a monoclonal antibody treatment developed to minimise the risk of severe COVID-19 in patients who have underlying health conditions.
Research led by the University of Sydney Institute for Infectious Diseases has reported genetic changes in the virus that causes COVID-19, associated with the development of . . .
Australian researchers have uncovered resistance mutations to Sotrovimab - a monoclonal antibody treatment developed to minimise the risk of severe COVID-19 in patients who have underlying health conditions.
Research led by the University of Sydney Institute for Infectious Diseases has reported genetic changes in the virus that causes COVID-19, associated with the development of . . .